About Peter Farmakis
Form D filings for 32 Biosciences in 2024 list Peter Farmakis as chief executive officer and director.
Peter Farmakis first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Peter Farmakis in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Peter Farmakis works with at each company, as listed on that company's latest Form D.
32 Biosciences, Inc. · Form D, May 31, 2024
JP
Joseph Pierre
Director
BY
Brian Yoor
Director
EC
Eugene Chang
Director
JC
Jaime Contreras
Director
JA
John Alverdy
Director